Filing Details
- Accession Number:
- 0000950170-24-094809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-09 16:30:19
- Reporting Period:
- 2024-06-05
- Accepted Time:
- 2024-08-09 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756262 | Transmedics Group Inc. | TMDX | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1980144 | P. Anil Ranganath | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-05 | 703 | $135.21 | 8,809 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-08-07 | 4,289 | $93.88 | 13,182 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-08-07 | 4,289 | $152.20 | 8,893 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-08-07 | 4,289 | $0.00 | 4,289 | $93.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,420 | 2033-08-01 | No | 4 | M | Direct |
Footnotes
- Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.
- Includes 84 shares of Issuer's Common Stock acquired on June 28, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of January 2, 2024 to June 28, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on January 2, 2024.
- The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.